Baird Medical Investment Holdings BDMD Institutional Ownership

Ownership Summary

Baird Medical Investment Holdings Ltd (NASDAQ:BDMD) is held by 9 institutional investors per 13F filings through March 2026.

• Their combined ownership stood at 1.7% of outstanding shares in March 2026, down from 1.9% in December 2025.
• They increased total shares held in Baird Medical Investment Holdings by 58.11% from the prior quarter, while the number of investors in BDMD increased 28.57% year over year.
• Of these 9 holders, 4 added to their stakes in Baird Medical Investment Holdings, 1 trimmed positions, and 4 made no changes.
• In total, institutional investors held 461.21K shares in Baird Medical Investment Holdings as of March 2026, up by 169.52K shares quarter on quarter, and up 103.78K shares year over year.
• Jpmorgan Chase & Co leads ownership in BDMD with 125.0K shares as of March 31, 2026, equal to 0.45% of outstanding shares.
• Top purchasers of BDMD stock for the quarter ending March 2026 included Jpmorgan Chase & Co (125.0K), JANE STREET GROUP, LLC (39.42K), UBS Group AG (33.96K), Morgan Stanley (20.0K).
• The biggest sellers of Baird Medical Investment Holdings for the quarter ending March 2026 included TWO SIGMA INVESTMENTS, LP (48.86K).
• Per Business Quant, the top 9 investors in BDMD for the quarter ending March 2026 include Jpmorgan Chase & Co (125.0K), HIGHBRIDGE CAPITAL MANAGEMENT LLC (125.0K), UBS Group AG (67.86K), TWO SIGMA INVESTMENTS, LP (46.59K), JANE STREET GROUP, LLC (39.42K), GEODE CAPITAL MANAGEMENT, LLC (25.44K), Morgan Stanley (20.0K), NATIONAL BANK OF CANADA /FI/ (11.7K), WOLVERINE ASSET MANAGEMENT LLC (205).